Cardiac, as well as neuronal, RGS4 stimulation might, thus, be advantageous in helping the failing heart cope with the toxic effects, both direct and indirect (via sympathetic hyperactivation), of SCFAs that are aberrantly upregulated in human heart failure [45,46]. This evidence concerns the gene RGS4 and heart failure.